SCHEMBL19203492

SCHEMBL19203492

Cc1cc(F)c(Cl)cc1C(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.39
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 2/20 0.39
TP53 P04637 2/20 0.39
HIF1A Q16665 2/20 0.39
RAPGEF4 Q8WZA2 2/20 0.33
CYP1A2 P05177 2/20 0.33
ALDH1A1 P00352 4/20 0.32
TDP1 Q9NUW8 2/20 0.32
POLB P06746 2/20 0.32
CA2 P00918 1/20 0.32
TYR P14679 1/20 0.32
ALOX15 P16050 2/20 0.31
KDM4E B2RXH2 1/20 0.31
MAPT P10636 1/20 0.31
ATP2A2 P16615 1/20 0.31
ATP2A3 Q93084 1/20 0.31
HTT P42858 1/20 0.31
APEX1 P27695 1/20 0.31
CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19163700 0.84 SMN1; SMN2 (0.38) SMN1; SMN2CYP2C9CYP2C19TP53HIF1A
SCHEMBL19203603 0.83 SMN1; SMN2 (0.39) SMN1; SMN2CYP2C9CYP2C19TP53HIF1A
SCHEMBL25789703 0.83 RAPGEF4 (0.38) RAPGEF4ALDH1A1TDP1
SCHEMBL17083896 0.82 SMN1; SMN2 (0.37) SMN1; SMN2CYP2C9CYP2C19TP53HIF1A
SCHEMBL12162725 0.81 SMN1; SMN2 (0.44) SMN1; SMN2CYP2C9CYP2C19TP53HIF1A
SCHEMBL15417372 0.81 CYP1A2 (0.38) SMN1; SMN2CYP2C9CYP2C19TP53HIF1A
SCHEMBL12390266 0.79 CYP1A2 (0.37) SMN1; SMN2CYP2C9CYP2C19TP53HIF1A
SCHEMBL19198900 0.79 SMN1; SMN2 (0.42) SMN1; SMN2CYP2C9CYP2C19TP53HIF1A
SCHEMBL26627971 0.78 CYP1A2 (0.33) SMN1; SMN2CYP2C9CYP2C19TP53HIF1A
SCHEMBL17083895 0.77 POLB (0.36) SMN1; SMN2CYP2C9CYP2C19TP53HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017132173-A1 MAYTANSINOID DERIVATIVES, CONJUGATES THEREOF, AND METHODS OF USE REGENERON PHARMACEUTICALS, INC. (US) 2017-08-03 WO disclosed